Sign in

    Jiten Sanghai

    Partner and Senior Analyst at Corre Partners Management, LLC

    Jiten Sanghai is a Partner and Senior Analyst at Corre Partners Management, LLC, specializing in investments in companies undergoing regulatory, operational, or financial transformation across multiple sectors. Prior to joining Corre in August 2018, he developed his expertise at UBS as an Analyst, advanced to Principal at JLL Partners where he managed large private equity portfolios, and served as Director at Strategic Value Partners, consistently generating strong returns for clients. At Corre Partners, Jiten oversees in-depth market analysis and portfolio strategy, though specific performance metrics and company names covered are not publicly disclosed. He brings nearly twenty years of experience in asset management and strategic investments; details on FINRA registration or securities licenses are not available from public sources.

    Jiten Sanghai's questions to U S PHYSICAL THERAPY INC /NV (USPH) leadership

    Jiten Sanghai's questions to U S PHYSICAL THERAPY INC /NV (USPH) leadership • Q2 2025

    Question

    Jiten Sanghai of Corre Partners Management, LLC inquired about the theoretical capacity for visits per clinic, given the record volumes, and the resulting margin accretion from incremental visits. He also asked about the staffing environment for the record number of de novo clinics planned for the year and the economics of recruiting new FTEs.

    Answer

    CEO Christopher Reading explained that clinic capacity is not limited by physical footprint but by staffing, and that visits per day can continue to grow by extending hours and filling slower times. He confirmed that incremental visits are more profitable as fixed costs are covered. He pointed to prior comments on investments in recruiting, school affiliations, and mentorship as key to staffing new de novos, noting that while the market is competitive, the company is successfully finding and retaining talent.

    Ask Fintool Equity Research AI